BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.021
0.00%
(0.00) 1D
Sep 4, 4:10:25 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
60.34M
Avg. vol.
7.45M
Volume
4.00M
52-wk high
A$0.17
52-wk low
A$0.02
EPS
-A$0.03
Shares outstanding
2.74B
No. of employees
11
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
60.34M
Avg. vol.
7.45M
Volume
4.00M
52-wk high
A$0.17
52-wk low
A$0.02
EPS
-A$0.03
Shares outstanding
2.74B
No. of employees
11
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd